NEIL Bajpayee
Nessuna posizione attualmente
Profilo
NEIL Bajpayee served as a Board of Directors member at Actuate Therapeutics, Inc. from 2019 to 2020.
Prior to that, he worked as an Investment Associate at Kairos Venture Investments LLC from 2018 to 2020.
Bajpayee received his undergraduate degree from The Pennsylvania State University in 2004 and his doctorate degree from the University of California in 2011.
Precedenti posizioni note di NEIL Bajpayee
Società | Posizione | Fine |
---|---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Investitore di Private Equity | 30/10/2020 |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Direttore/Membro del Consiglio | 30/10/2020 |
Formazione di NEIL Bajpayee
The Pennsylvania State University | Undergraduate Degree |
University of California | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Finance |
Actuate Therapeutics, Inc.
Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- NEIL Bajpayee